Xh. Chen et Qj. Pittman, Vasopressin and amastatin induce V-1-receptor-mediated suppression of excitatory transmission in the rat parabrachial nucleus, J NEUROPHYS, 82(4), 1999, pp. 1689-1696
We examined actions of arginine vasopressin (AVP) and amastatin (an inhibit
or of the aminopeptidase that cleaves AVP) on synaptic currents in slices o
f rat parabrachial nucleus using the nystatin-perforated patch recording te
chnique. AVP reversibly decreased the amplitude of the evoked, glutamate-me
diated, excitatory postsynaptic current (EPSC) with an increase in paired-p
ulse ratio. No apparent changes in postsynaptic membrane properties were re
vealed by ramp protocols, and the inward current induced by a brief applica
tion of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid was unchan
ged after AVP. The reduction induced by 1 mu M AVP could be blocked by a V-
1 AVP receptor antagonist, [d(CH2)(5)(1)-O-Me-Tyr(2)-Arg(8)]-vasopressin (M
anning compound, 10 mu M). Bath application of an aminopeptidase inhibitor,
amastatin(10 mu M), reduced the evoked EPSC, and AVP induced further synap
tic depression in the presence of amastatin. Amastatin's effects also could
be antagonized by the Manning compound. Corticotropin-releasing hormone sl
ightly increased the EPSC at 1 mu M, and coapplication with AVP attenuated
the AVP response. Pretreatment of slices with 1 mu g/ml cholera toxin or 0.
5 mu g/ml pertussis toxin for 20 h did not significantly affect AVP's synap
tic action. The results suggest that AVP has suppressant effects on glutama
tergic transmission by acting at V-1 AVP receptors, possibly through a pres
ynaptic mechanism involving a pertussis-toxin- and cholera-toxin-resistant
pathway.